F-star Therapeutics, Inc Earning Date (FSTX)

USA |NASDAQ |USD

FSTX Earnings Date

|
Report Date Period Ending EPS Forecast Last Quarter's EPS Last Year's EPS
Mar 28, 2022 Dec 2021 $-0.69 - $-2.10
Report Date Period Ending Revenue Forecast Last Quarter’s Revenue Last Year’s Revenue
Mar 28, 2022 Dec 2021 $1.17M - $11.26M

F-Star Therapeutics, Inc's next earnings date is Monday, Mar 28, 2022 for the fiscal quarter ending Dec 2021.

FSTX Earnings Date & History Chart

FSTX Earnings & Revenue Forecast

FSTX Earnings Forecast

|
Period End # of Analysts EPS Forecast Low EPS Forecast High EPS Forecast
Dec 2021 7 $-0.69 $-0.88 $-0.48
Period End # of Analysts EPS Forecast Low EPS Forecast High EPS Forecast
Dec 2021 6 $-3.06 $-3.31 $-2.72
Dec 2022 7 $-2.63 $-3.47 $-1.49

FSTX Earnings Revision Trend

|
Period End Up/Down 1M 1M Trend 2M Trend 3M Trend
Dec 2021 0 / 0 $-0.69 $-0.61 $-0.61
Period End Up/Down 1M 1M Trend 2M Trend 3M Trend
Dec 2021 0 / 0 $-3.06 $-2.88 $-2.88
Dec 2022 0 / 0 $-2.63 $-2.72 $-2.63

FSTX Revenue Forecast

|
Period End # of Analysts Revenue Forecast Low Revenue Forecast High Revenue Forecast
Dec 2021 7 $1.17M $0.00 $7.00M
Period End # of Analysts EPS Forecast Low EPS Forecast High EPS Forecast
Dec 2021 7 $7.06M $2.90M $14.90M
Dec 2022 7 $4.47M $0.00 $15.46M

FSTX Earnings Date & Revenue History

FSTX Earnings History

|
Show More
Show More

FSTX Revenue History

|
Show More
Show More

F-Star Therapeutics, Inc Next Earnings Date & Report

FSTX Next Earnings Date & Report Preview: Dec 2021 (FQ)

FSTX's next earnings date is Monday, Mar 28, 2022 for the fiscal quarter ending Dec 31, 2021.

According to analysts, the average EPS estimation for F-Star Therapeutics, Inc's next quarterly earnings is $-0.69, with a low EPS estimation of $-0.88, and a high estimation of $-0.48.

Over the last 1 month, EPS estimates have seen 0 upward revisions and 0 downward. The EPS 1 month trend is $-0.69, the last 2 month trend is $-0.61, and the 3 month trend is $-0.61.

Based on analysts, the average revenue estimation is $1.17M, with a low revenue estimation of $0.00, and a high estimation of $7.00M.

F-Star Therapeutics, Inc Previous Earnings Dates & Reports

FSTX Previous Earnings Date & Report Recap: Sep 2021 (FQ)

F-Star Therapeutics, Inc's previous earnings date was Nov 1, 2021 for its fiscal quarter ended Sep 30, 2021.

FSTX Previous Earnings Date & Report Recap: Dec 2020 (FY)

F-Star Therapeutics, Inc's previous annual earnings date was Mar 29, 2021 for its fiscal year ended Dec 31, 2020.

FSTX's earnings per share (EPS) was $-6.44, missing the consensus analysts forecast of $-1.77 by 263.80% , and higher than the previous year's EPS (Dec 2019) by -41.29%.

Revenues were $11.26M, better than the forecast of $11.26M by 0.00%, and down by -60.26% from previous year's revenue.

The company reported a net income of $-25.62M.

F-Star Therapeutics, Inc reported a free cash flow of $-16.96M for its fiscal year, compared to $-22.24M a year ago.

The company ended the fiscal year with $3.16M in total debt, a decrease of -79.70% compared to the previous year.